Your account is not claimed yet. You can sign up with ORCID to claim your account.

Matthew J Maurer (Matt J Maurer, Mathew S Maurer, Matthew Maurer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 68

Top Venues

Blood cancer journal

Blood advances

British journal of haematology

American journal of hematology

Mayo Clinic Rochester

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Rochester Jan 15o 2002

United States

Statistician :: Health Sciences Research

Publications

Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, Raphael Mwangi, Matthew J Maurer, Diego R Villa, Tim McDonnell, Andrew Feldman, Jonathon B Cohen, Thomas Habermann, Elias Campo, Guillem Clot, Marco M Bühler, Marta Kulis, José Ignacio Martin-Subero, Eva Giné, James R Cook, Brian T Hill, Philipp W Raess, Klaus H Beiske, Alexander Reichart, Sylvia Hartmann, Harald Holte, David Scott, Lisa M Rimsza
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab. British journal of haematology (2023)
Diego R Villa, Aixiang Jiang, Carlo Visco, Nicola Crosbie, Rory McCulloch, Michael J Buege, Anita Kumar, David A Bond, Jonas Paludo, Matthew J Maurer, Gita Thanarajasingam, Katharine Louise Lewis, Chan Yoon Y Cheah, Joachim Bæch, Tarec Christoffer El-Galaly, Laveniya Kugathasan, David W Scott, Alina S Gerrie, David Lewis
Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma. Blood advances (2023)
Dia A Smiley, Andrew J Einstein, Akiva Mintz, Mrinali Shetty, Nicholas Chan, Stephen T Helmke, Ketan Bhatia, Kim Goldner, Thomas H Brannagan, Denisse D Santana, Matthew J Maurer
Gene Silencing Therapy in Hereditary (Variant) Transthyretin Cardiac Amyloidosis: A Puzzling Case of Decreasing Pyrophosphate Uptake on Scintigraphy. Circulation. Cardiovascular imaging (2023)
Lusha W Liang, Kohei Hasegawa, Matthew J Maurer, Muredach P Reilly, Michael A Fifer, Yuichi J Shimada
Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways. Circulation. Heart failure (2023)
Cristina Correia, Matthew J Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Côme Bommier, Emanuele Zucca, Sylvie Chevret, Annarita Conconi, Grzegorz S Nowakowski, Matthew J Maurer, James R Cerhan, Catherine Thieblemont, Jerome Lambert
Early Complete Response as Validated Surrogate Marker in Extranodal Marginal Zone Lymphoma Systemic Therapy. Blood (2023)
Allison M Bock, Jennifer Jane Gile, Melissa C Larson, Kittika Poonsombudlert, Reema K Tawfiq, Seth Maliske, Matthew J Maurer, Brian F Kabat, Jonas Paludo, David J Inwards, Sabarish Ayyappan, Brian K Link, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski, James R Cerhan, Umar Farooq, Yucai Wang
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study. Blood cancer journal 13 (1) (2023)
Yucai Wang, Preetesh Jain, Frederick L Locke, Matthew J Maurer, Matthew J Frank, Javier L Muñoz, Saurabh Dahiya, Amer M Beitinjaneh, Miriam T Jacobs, Joseph P McGuirk, Julie M Vose, Andre H Goy, Charalambos Andreadis, Brian T Hill, Kathleen A Dorritie, Olalekan O Oluwole, Abhinav Deol, Jonas Paludo, Bijal Shah, Trent P Wang, Rahul Banerjee, David Bernard Miklos, Aaron P Rapoport, Lazaros Lekakis, Armin Ghobadi, Sattva S Neelapu, Yi Lin, Michael L Wang, Michael D Jain
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Cristina Correia, Matthew J Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Zhi-Zhang Yang, Hyo Jin Kim, Hongyan Wu, Xinyi Tang, Yue Yu, Jordan E Krull, Daniel P Larson, Raymond M Moore, Matthew J Maurer, Kevin D Pavelko, Shahrzad Jalali, Joshua C Pritchett, Rekha Mudappathi, Junwen Wang, Jose C Villasboas Bisneto, Patrizia Mondello, Anne J Novak, Stephen M Ansell
T-cell phenotype including CD57 + T follicular helper cells in the tumor microenvironment correlate with a poor outcome in follicular lymphoma. Blood cancer journal 13 (1) (2023)
Katharine Louise Lewis, Lasse Hjort Jakobsen, Diego R Villa, Karin E Smedby, Kerry J Savage, Toby Andrew Eyre, Kate Cwynarski, Mark J Bishton, Christopher Paul Fox, Eliza A Hawkes, Matthew J Maurer, Tarec C El-Galaly, Chan Yoon Y Cheah, null null
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Avni Madhani, Natalia Sabogal, Daniel Massillon, Ludwine D Paul, Carlos Rodriguez, Denise Fine, Stephen T Helmke, Morgan Winburn, Damian Kurian, Farbod Raiszadeh, Sergio Teruya, Elizabeth Cohn, Andrew J Einstein, Edward J Miller, Lawreen H Connors, Matthew J Maurer, Frederick L Ruberg
Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. Journal of the American Heart Association (2023)
Cristina Correia, Matthew J Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Joshua Saef, Trejeeve Martyn, Lauren Ives, Lori R Roth, Justin L Grodin, Matthew J Maurer, Mazen Hanna, Wai Hong Wilson Tang
Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information. Circulation. Heart failure (2023)
Evandro D Bezerra, Madiha Iqbal, Javier Munoz, Arushi Khurana, Yucai Wang, Matthew J Maurer, Radhika Bansal, Matthew Hathcok, N Nora Bennani, Hemant S Murthy, Allison C Rosenthal, Jonas Paludo, Jose C Villasboas Bisneto, Patrick B Johnston, Thomas M Habermann, Stephen M Ansell, Januario E Castro, Thomas E Witzig, Mohamed A Kharfan-Dabaja, Grzegorz S Nowakowski, Yi Lin
Barriers to enrollment in clinical trials of patients with aggressive B-Cell NHL that progressed after CAR T-cell therapy. Blood advances (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian K Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew J Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Aung M Tun, Arushi Khurana, Raphael Mwangi, Brian K Link, Yucai Wang, Andrew L Feldman, Carrie A Thompson, Anne J Novak, Jose C Villasboas Bisneto, Gita Thanarajasingam, Umar Farooq, Sergei Syrbu, Grzegorz S Nowakowski, Thomas E Witzig, Stephen M Ansell, Lisa M Rimsza, James R Cerhan, Thomas M Habermann, Matthew J Maurer
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study. Blood advances 6 (17) (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian K Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew J Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
R Andrew Harkins, Sharvil Piyush Patel, Michelle J Lee, Jeffrey M Switchenko, Stephen M Ansell, Nancy L Bartlett, Kristie A Blum, Amanda F Cashen, Carla Casulo, Jonathan W Friedberg, Patrick B Johnston, Brad S Kahl, John P Leonard, Brian K Link, Izidore S Lossos, Peter Martin, Matthew J Maurer, Neha Mehta-Shah, Patrick M Reagan, Jason R Westin, Jean L Koff, Christopher R Flowers
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey. Blood advances 6 (9) (2022)
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, Jonathan W Friedberg, Andrea Gallamini, Eliza A Hawkes, David C Hodgson, Peter W M Johnson, Brian K Link, Eric Mou, Kerry J Savage, Pier Luigi Luigi Zinzani, Matthew J Maurer, Andrew M Evens
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Yuichi J Shimada, Yoshihiko Raita, Lusha W Liang, Matthew J Maurer, Kohei Hasegawa, Michael A Fifer, Muredach P Reilly
Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling. Circulation. Genomic and precision medicine (2022)
Sanjal H Desai, Levi D Pederson, Betsy LaPlant, Raphael Mwangi, Matthew J Maurer, Jason R Young, William R Macon, Rebecca L King, Yucai Wang, James R Cerhan, Andrew L Feldman, David J Inwards, Ivana Micallef, Patrick Johnston, Luis F Porrata, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts. Blood cancer journal 12 (5) (2022)
Danny Luan, Tolulope Fatola, Ahmed Toure, Christopher R Flowers, Brian K Link, Jonathan W Friedberg, Jonathon B Cohen, Brad S Kahl, Izidore S Lossos, Loretta Nastoupil, Matthew J Maurer, James R Cerhan, Peter Martin
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis. Blood advances 6 (15) (2022)
Matthew J Maurer, Preston Dunnmon, Mariana Fontana, Cristina Candida Quarta, Krishna Prasad, Ronald M Witteles, Claudio Rapezzi, James E Signorovitch, Isabelle Lousada, Giampaolo Merlini
Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group. Circulation. Heart failure 15 (6) (2022)
Jignesh K Patel, Matthew J Maurer
The Future for Patients With Transthyretin Cardiac Amyloidosis Is Looking Brighter. Circulation 146 (22) (2022)
Yucai Wang, Shouhao Zhou, Xinyue Qi, Fang Yang, Matthew J Maurer, Thomas M Habermann, Thomas E Witzig, Michael L Wang, Grzegorz S Nowakowski
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials. Blood cancer journal 12 (1) (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian K Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew J Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian K Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew J Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Sanjal H Desai, Raphael Mwangi, Wern Lynn Ng, Rebecca L King, Matthew J Maurer, James R Cerhan, Andrew L Feldman, Umar Farooq, Eric Mou, Thomas M Habermann, Carrie A Thompson, Yucai Wang, Thomas E Witzig, Grzegorz S Nowakowski
Increasing tissue requirements in lymphoma trials may exclude patients with high risk disease or worse prognosis. Blood advances (2022)
Sarah A M Cuddy, Yesh Datar, Gavin Ovsak, Sunil E Saith, Sean P Murphy, Camden P Bay, Mia Haddad, Brian Lilleness, Varsha Muralidhar, Alexandra Pipilas, Jacqueline Vuong, Eric Guardino, Matthew J Maurer, Frederick L Ruberg, Rodney H Falk, Sharmila Dorbala
Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac Amyloidosis. Circulation. Cardiovascular imaging 15 (11) (2022)
Grzegorz S Nowakowski, Matthew J Maurer, James R Cerhan, Debarshi Dey, Laurie Helen Sehn
Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphoma. American journal of hematology (2022)
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, Jonathan W Friedberg, Andrea Gallamini, Eliza A Hawkes, David C Hodgson, Peter W M Johnson, Brian K Link, Eric Mou, Kerry J Savage, Pier Luigi Luigi Zinzani, Matthew J Maurer, Andrew M Evens
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Christopher S Strouse, Melissa C Larson, Shawna L Ehlers, Kathleen J Yost, Matthew J Maurer, Stephen M Ansell, David J Inwards, Patrick B Johnston, Ivana N Micallef, Brian K Link, Umar Farooq, James R Cerhan, Carrie A Thompson
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis. JCO oncology practice 18 (7) (2022)
Alexandra S Higgins, Hidong Kim, Laura Harper, Thomas M Habermann, Grzegorz S Nowakowski, Carrie A Thompson, Patrick Johnston, Thomas E Witzig, Cristine Allmer, Matthew J Maurer, James R Cerhan, Jason R Young, Gita Thanarajasingam
Testicular FDG-PET/CT uptake threshold in aggressive lymphomas. American journal of hematology 96 (3) (2021)
Dai Chihara, Melissa C Larson, Dennis P Robinson, Carrie A Thompson, Matthew J Maurer, Carla Casulo, Priyanka A Pophali, Brian K Link, Thomas M Habermann, Andrew L Feldman, Christopher R Flowers, James R Cerhan, Lindsay M Morton
Body mass index and survival of patients with lymphoma. Leukemia & lymphoma 62 (11) (2021)
Barry J Maron, Martin S Maron, Matthew J Maurer, Ethan J Rowin, Bradley A Maron, Nazzareno Galiè
Cardiovascular Diseases That Have Emerged From the Darkness. Journal of the American Heart Association 10 (20) (2021)
Kang Le, Linda E Wellik, Matthew J Maurer, Ellen Darcy McPhail, Thomas E Witzig, Mamta Gupta
JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis. Blood cancer journal 11 (3) (2021)
Arushi Khurana, Matthew J Maurer
Reversing the restrictive trend in diffuse large B-cell lymphoma trial eligibility: it's time to open the gates! British journal of haematology 193 (4) (2021)
null Arushi Khurana, Raphael Mwangi, Stephen M Ansell, Thomas M Habermann, James R Cerhan, Christopher Strouse, Brian K Link, Yucai Wang, Rebecca L King, William R Macon, Jose C Villasboas Bisneto, Thomas E Witzig, Matthew J Maurer, Grzegorz S Nowakowski
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era. Blood cancer journal 11 (7) (2021)
Matthew J Maurer, Frederick L Ruberg
Cardiac Scintigraphy and Screening for Transthyretin Cardiac Amyloidosis: Caveat Emptor. Circulation 144 (13) (2021)
Geffen Kleinstern, Melissa C Larson, Stephen M Ansell, Carrie A Thompson, Grzegorz S Nowakowski, Timothy G Call, Dennis P Robinson, Matthew J Maurer, Raphael Mwangi, Andrew L Feldman, Neil E Kay, Anne J Novak, Thomas M Habermann, Susan L Slager, James R Cerhan
Vaccination History and Risk of Lymphoma and Its Major Subtypes. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Nicholas J Boddicker, Melissa C Larson, Alessia Castellino, Joerg Herrmann, David J Inwards, Gita Thanarajasingam, Matthew J Maurer, Cristine Allmer, Thomas E Witzig, Grzegorz S Nowakowski, Thomas M Habermann, Hector R Villarraga, Susan L Slager, James R Cerhan, Carrie A Thompson
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. American journal of hematology 96 (8) (2021)
Matthew J Maurer, Lasse H Jakobsen, Raphael Mwangi, Norbert Schmitz, Umar Farooq, Cristopher R Flowers, Peter de Nully Brown, Carrie A Thompson, Henrik Frederiksen, David Cunningham, Judit Jørgensen, Viola Poeschel, Grzegorz Nowakowski, John F Seymour, Francesco Merli, Corinne Haioun, Hervé Ghesquieres, Marita Ziepert, Hervé Tilly, Gilles Salles, Qian Shi, Tarec C El-Galaly, Thomas M Habermann
Relapsed/Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma. American journal of hematology 96 (5) (2021)
Arushi Khurana, Raphael Mwangi, Grzegorz S Nowakowski, Thomas M Habermann, Stephen M Ansell, Betsy R LaPlant, Brian K Link, James R Cerhan, Matthew J Maurer, Thomas E Witzig
Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (15) (2021)
Edward J Bataillard, Chan Yoon Y Cheah, Matthew J Maurer, Arushi Khurana, Toby Andrew Eyre, Tarec Christoffer El-Galaly
Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review. Blood advances 5 (9) (2021)
Alessia Castellino, Yucai Wang, Melissa C Larson, Matthew J Maurer, Brian K Link, Umar Farooq, Andrew L Feldman, Sergei I Syrbu, Thomas M Habermann, Jonas Paludo, David J Inwards, Thomas E Witzig, Stephen M Ansell, Cristine Allmer, Susan L Slager, Jonathon B Cohen, Peter Martin, James R Cerhan, Grzegorz S Nowakowski
Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes. Blood advances (2021)
Jordan E Krull, Kerstin Wenzl, Keenan T Hartert, Michelle K Manske, Vivekananda Sarangi, Matthew J Maurer, Melissa C Larson, Grzegorz S Nowakowski, Stephen M Ansell, Ellen McPhail, Thomas M Habermann, Brian K Link, Rebecca L King, James R Cerhan, Anne J Novak
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients. Blood cancer journal 10 (11) (2020)
Steven R Hwang, Alexandra S Higgins, Natalia E Castillo Almeida, Betsy LaPlant, Matthew J Maurer, Stephen M Ansell, Thomas E Witzig, Gita Thanarajasingam, N Nora Bennani
Effect of antibiotic use on outcomes in patients with Hodgkin lymphoma treated with immune checkpoint inhibitors. Leukemia & lymphoma 62 (1) (2020)
Keenan T Hartert, Kerstin Wenzl, Jordan E Krull, Michelle Manske, Vivekananda Sarangi, Yan Asmann, Melissa C Larson, Matthew J Maurer, Susan Slager, William R Macon, Rebecca L King, Andrew L Feldman, Anita K Gandhi, Brian K Link, Thomas M Habermann, Zhi-Zhang Yang, Stephen M Ansell, James R Cerhan, Thomas E Witzig, Grzegorz S Nowakowski, Anne J Novak
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL. Leukemia 35 (2) (2020)
Lawrence D Kaplan, Matthew J Maurer, Wendy Stock, Nancy L Bartlett, Noreen Fulton, Adam Pettinger, John C Byrd, Kristie A Blum, Ann S LaCasce, Eric D Hsi, Yi Tian Liu, David W Scott, David Hurd, Amy S Ruppert, Francisco Hernandez-Ilizaliturri, John P Leonard, Bruce D Cheson
Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB/Alliance 50403. American journal of hematology 95 (6) (2020)
Priyanka A Pophali, Lisa M Marinelli, Rhett P Ketterling, Reid G Meyer, Ellen D McPhail, Paul J Kurtin, Raphael Mwangi, Matthew J Maurer, Thomas Habermann, Rebecca L King
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease? Blood cancer journal 10 (1) (2020)
Priyanka A Pophali, Melissa C Larson, Allison C Rosenthal, Dennis Robinson, Thomas M Habermann, Gita Thanarajasingam, Timothy Call, Cristine Allmer, Umar Farooq, Matthew J Maurer, Kathleen J Yost, James R Cerhan, Carrie A Thompson
The association of health behaviors with quality of life in lymphoma survivors. Leukemia & lymphoma 62 (2) (2020)
Artur A Serebrenik, Prokopios P Argyris, Matthew C Jarvis, William L Brown, Martina Bazzaro, Rachel Isaksson Vogel, Britt K Erickson, Sun-Hee Lee, Krista M Goergen, Matthew J Maurer, Ethan P Heinzen, Ann L Oberg, Yajue Huang, Xiaonan Hou, S John Weroha, Scott H Kaufmann, Reuben S Harris
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Matthew J Maurer
POD24 in MZL: a means to an end or an end point in itself? Blood 134 (10) (2020)
Yucai Wang, Kerstin Wenzl, Michelle K Manske, Yan W Asmann, Vivekananda Sarangi, Patricia T Greipp, Jordan E Krull, Keenan Hartert, Rong He, Andrew L Feldman, Matthew J Maurer, Susan L Slager, Grzegorz S Nowakowski, Thomas M Habermann, Thomas E Witzig, Brian K Link, Stephen M Ansell, James R Cerhan, Anne J Novak
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma. Blood cancer journal 9 (9) (2019)
Michael Roost Clausen, Matthew J Maurer, Sinna Pilgaard Ulrichsen, Thomas S Larsen, Bodil Himmelstrup, Dorthe Rønnov-Jessen, Brian K Link, Andrew L Feldman, Susan L Slager, Grzegorz S Nowakowski, Carrie A Thompson, Per Trøllund Pedersen, Jakob Madsen, Robert S Pedersen, Jette Sønderskov Gørløv, James R Cerhan, Mette Nørgaard, Francesco D'Amore
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy. Clinical epidemiology 11 (2019)
Yucai Wang, Matthew J Maurer, Melissa C Larson, Cristine Allmer, Andrew L Feldman, N Nora Bennani, Carrie A Thompson, Luis F Porrata, Thomas M Habermann, Thomas E Witzig, Stephen M Ansell, Susan L Slager, Grzegorz S Nowakowski, James R Cerhan
Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphoma. British journal of haematology 186 (6) (2019)
Alyssa I Clay-Gilmour, Abdul R Rishi, Lynn R Goldin, Alexandra J Greenberg-Worisek, Sara J Achenbach, Kari G Rabe, Matthew J Maurer, Neil E Kay, Tait D Shanafelt, Timothy G Call, J Brice Weinberg, Nicola J Camp, James R Cerhan, Jose Leis, Aaron Norman, David L Murray, Sundararajan Vincent Rajkumar, Neil E Caporaso, Ola Landgren, Mary L McMaster, Susan L Slager, Celine M Vachon
Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Blood cancer journal 9 (8) (2019)
Fredrik Ellin, Matthew J Maurer, Line Srour, Umar Farooq, Mats Jerkeman, Joseph M Connors, Karin E Smedby, N Nora Bennani, Stephen M Ansell, Graham W Slack, James R Cerhan, Thomas Relander, Andrew L Feldman, Kerry J Savage
Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas. British journal of haematology 186 (3) (2019)
Kerstin Wenzl, Michelle K Manske, Vivekananda Sarangi, Yan W Asmann, Patricia T Greipp, Hanna R Schoon, Esteban Braggio, Matthew J Maurer, Andrew L Feldman, Thomas E Witzig, Susan L Slager, Stephen M Ansell, James R Cerhan, Anne J Novak
Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma. Blood cancer journal 8 (10) (2018)
Praful Ravi, Shaji K Kumar, James R Cerhan, Matthew J Maurer, David Dingli, Stephen M Ansell, S Vincent Rajkumar
Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies. Blood cancer journal 8 (3) (2018)
Jing Jing Han, Megan O'byrne, Mary J Stenson, Matthew J Maurer, Linda E Wellik, Andrew L Feldman, Ellen D McPhail, Thomas E Witzig, Mamta Gupta
Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma. Blood cancer journal 8 (11) (2018)
Brian T Hill, Loretta Nastoupil, Allison M Winter, Melody R Becnel, James R Cerhan, Thomas M Habermann, Brian K Link, Matthew J Maurer, Bita Fakhri, Prathima Reddy, Stephen D Smith, Dhruvika Mukhija, Deepa Jagadeesh, Amrita Desai, Juan Pablo Alderuccio, Izidore S Lossos, Pooja Mehra, Craig A Portell, Max L Goldman, Oscar Calzada, Jonathon B Cohen, Mohammad J Hussain, Nilanjan Ghosh, Paolo Caimi, Timothy Tiutan, Peter Martin, Abhigna Kodali, Andrew M Evens, Brad S Kahl
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma. British journal of haematology 184 (4) (2018)
Angelo Fama, Jinhua Xiang, Brian K Link, Cristine Allmer, Donna Klinzman, Andrew L Feldman, Grzegorz S Nowakowski, Mark Liebow, Melissa C Larson, Matthew J Maurer, Stephen M Ansell, Anne J Novak, Yan W Asmann, Susan L Slager, Timothy G Call, Thomas M Habermann, James R Cerhan, Jack T Stapleton
Human Pegivirus infection and lymphoma risk and prognosis: a North American study. British journal of haematology 182 (5) (2018)
Geffen Kleinstern, Matthew J Maurer, Mark Liebow, Thomas M Habermann, Jean L Koff, Cristine Allmer, Thomas E Witzig, Grzegorz S Nowakowski, Ivana N Micallef, Patrick B Johnston, David J Inwards, Carrie A Thompson, Andrew L Feldman, Brian K Link, Christopher Flowers, Susan L Slager, James R Cerhan
History of autoimmune conditions and lymphoma prognosis. Blood cancer journal 8 (8) (2018)
Umar Farooq, Matthew J Maurer, Carrie A Thompson, Gita Thanarajasingam, David J Inwards, Ivana Micallef, William Macon, Sergei Syrbu, Tasha Lin, Yi Lin, Stephen M Ansell, Grzegorz S Nowakowski, Thomas M Habermann, James R Cerhan, Brian K Link
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy. British journal of haematology 179 (1) (2017)
Gita Thanarajasingam, Matthew J Maurer, Umar Farooq, Patrick B Johnston, Carrie A Thompson, Nabila N Bennani, Stephen M Ansell, Luis F Porrata, William R Macon, Sergei I Syrbu, James R Cerhan, Thomas M Habermann, Brian K Link, Thomas E Witzig, Grzegorz S Nowakowski
Event-free survival at 24 months captures central nervous system relapse of systemic diffuse large B-cell lymphoma in the immunochemotherapy era. British journal of haematology 183 (1) (2017)
Mary-Kate Malecek, Adam M Petrich, Shaina Rozell, Benjamin Chu, Steven Trifilio, Natalie Galanina, Matthew J Maurer, Umar Farooq, Brian K Link, Grzegorz S Nowakowski, Chadi Nabhan, Ayed O Ayed
Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab. American journal of hematology 92 (11) (2017)
Muhammad A Mir, Matthew J Maurer, Steven C Ziesmer, Susan L Slager, Thomas Habermann, William R Macon, Brian K Link, Sergei Syrbu, Thomas Witzig, Jonathan W Friedberg, Oliver Press, Michael LeBlanc, James R Cerhan, Anne Novak, Stephen M Ansell
Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma. Blood 125 (6) (2014)

Matthew J Maurer.css-eqlu8i{font-size:small;padding-left:4px;} (Matt J Maurer, Mathew S Maurer, Matthew Maurer)

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew J Maurer (Matt J Maurer, Mathew S Maurer, Matthew Maurer)